Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in Brazil with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Status: Unknown status Country / region: Brazil Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federal University of Paraíba3
Centro Universitário Augusto Motta1
D'Or Institute for Research and Education1
Federal University of São Paulo1
Universidade Federal de Pernambuco1
University of Sao Paulo1
University of the State of Santa Catarina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome9
COVID-192
Respiratory Tract Infections2
Cardiovascular Abnormalities1
Cardiovascular Diseases1
Cognitive Dysfunction1
Coronavirus Infections1
Fatigue1
Inflammation1
Pain1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.